These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17461742)

  • 1. Tafenoquine: a promising new antimalarial agent.
    Crockett M; Kain KC
    Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tafenoquine: First Global Approval.
    Frampton JE
    Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafenoquine: the new kid on the block.
    Chen V; Daily JP
    Curr Opin Infect Dis; 2019 Oct; 32(5):407-412. PubMed ID: 31305490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
    J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia.
    Yang H; Wang J; Liu H; Li X; Nie R; Li C; Wang H; Wang Q; Cao Y; Cui L
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
    Ebstie YA; Abay SM; Tadesse WT; Ejigu DA
    Drug Des Devel Ther; 2016; 10():2387-99. PubMed ID: 27528800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
    Vélez ID; Hien TT; Green JA; Martin A; Sharma H; Rousell VM; Breton JJ; Ernest TB; Rolfe K; Taylor M; Mohamed K; Jones SW; Chau NH; Hoa NT; Duparc S; Tan LK; Goyal N
    Lancet Child Adolesc Health; 2022 Feb; 6(2):86-95. PubMed ID: 34871570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
    Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
    Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
    Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine: a toxicity overview.
    Chu CS; Hwang J
    Expert Opin Drug Saf; 2021 Mar; 20(3):349-362. PubMed ID: 33306921
    [No Abstract]   [Full Text] [Related]  

  • 15. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S; Nasveld P; Edstein MD
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
    Edstein MD; Kocisko DA; Brewer TG; Walsh DS; Eamsila C; Charles BG
    Br J Clin Pharmacol; 2001 Dec; 52(6):663-70. PubMed ID: 11736877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tafenoquine for travelers' malaria: evidence, rationale and recommendations.
    Baird JK
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30380095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
    Dow GS; McCarthy WF; Reid M; Smith B; Tang D; Shanks GD
    Malar J; 2014 Feb; 13():49. PubMed ID: 24502679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria chemoprophylaxis with tafenoquine: a randomised study.
    Lell B; Faucher JF; Missinou MA; Borrmann S; Dangelmaier O; Horton J; Kremsner PG
    Lancet; 2000 Jun; 355(9220):2041-5. PubMed ID: 10885356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafenoquine: A Step toward Malaria Elimination.
    Lu KY; Derbyshire ER
    Biochemistry; 2020 Mar; 59(8):911-920. PubMed ID: 32073254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.